ersentilide has been researched along with verapamil in 1 studies
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
Studies (ersentilide) | Trials (ersentilide) | Recent Studies (post-2010) (ersentilide) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
9 | 0 | 0 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, I; Kohlhardt, M | 1 |
1 other study(ies) available for ersentilide and verapamil
Article | Year |
---|---|
Distinct modes of blockade in cardiac ATP-sensitive K+ channels suggest multiple targets for inhibitory drug molecules.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Binding Sites; Cells, Cultured; Glyburide; Imidazoles; Kinetics; Membrane Potentials; Myocardium; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Propanolamines; Rats; Sotalol; Verapamil | 1994 |